Abbott Laboratories
- Price
- 103.06 USD
- Fair value
- 51.60 USD
- Discount to fair value
- −100%
- Mkt cap
- 179.51B
- P/E
- 27.5×
- P/B
- 3.44×
- EV
- 184.85B
- Div yield
- 2.29%
- ROE
- 12.5%
- Net margin
- 14.7%
Current price103.06USD
Fair value (est., median)51.6USD
UndervaluedFair valueOvervalued
+99.7% above fair valueWould need to fall ~49.9% to reach fair value.
Median ofDCF 69.11DDM 41.54Graham 52.36Residual Income 51.6Earnings Power 44.5
Health Check
47.3
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Healthy balance sheet.
Risks
- Trades 99.7% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 19 years · FY2007–FY2025
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 43.08B | 43.65B | 40.11B | 41.95B | 44.33B |
| Net Income | 7.07B | 6.93B | 5.72B | 13.40B | 6.52B |
| Net Margin | 16.4% | 15.9% | 14.3% | 31.9% | 14.7% |
| Operating Cash Flow | 10.53B | 9.58B | 7.26B | 8.56B | 9.57B |
| OCF Margin | 24.5% | 21.9% | 18.1% | 20.4% | 21.6% |
| Capital Expenditure | 1.89B | 1.78B | 2.20B | 2.21B | 2.17B |
| Free Cash Flow | 8.65B | 7.80B | 5.06B | 6.35B | 7.39B |
| FCF Margin | 20.1% | 17.9% | 12.6% | 15.1% | 16.7% |
| FCF Conversion | 122.3% | 112.6% | 88.4% | 47.4% | 113.4% |
| EPS (Diluted) | 4.06/sh | 3.98/sh | 3.29/sh | 7.69/sh | 3.75/sh |
| Dividend / Share | 1.84/sh | 1.90/sh | 2.04/sh | 2.20/sh | 2.36/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.29%
Dividend / share2.36 USD
If you invest
USD
Shares (≈)97
Est. annual income229.22 USD
At this rate, dividends alone return your capital in ~43.6 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | 0.63 | 0.63 | — | 1.26 | 1.3% |
| 2025 | — | — | — | — | 2.36 | 1.8% |
| 2024 | — | — | — | — | 2.20 | 1.9% |
| 2023 | 0.51 | 0.51 | 0.51 | 0.51 | 2.04 | 1.9% |
| 2022 | 0.47 | 0.47 | 0.47 | 0.47 | 1.90 | 1.8% |
Corporate actions
DCash Dividend
0.63 USD /sh2026-07-15
DCash Dividend
0.63 USD /sh2026-04-15
DCash Dividend
0.55 USD /sh2024-07-15
DCash Dividend
0.55 USD /sh2024-04-12
DCash Dividend
0.55 USD /sh2024-01-11
DCash Dividend
0.51 USD /sh2023-10-12
DCash Dividend
0.51 USD /sh2023-07-13
DCash Dividend
0.51 USD /sh2023-04-13
DCash Dividend
0.51 USD /sh2023-01-12
DCash Dividend
0.47 USD /sh2022-10-13
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
69.11 USD
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
41.54 USD
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
52.36 USD
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
51.60 USD
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
44.50 USD
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)51.60 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 8.86%
- CAPM cost of equity
- 9.15%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Abbott Laboratories regularly?
Starting year
- Invested
- 1K/yr · 43K total(1984 → today · 43 yrs)
- your value today is
- 641.2K USD
- Total return
- +1391.2%(+254.0% Dividends · +1137.1% Capital gain)
- Annualised (IRR)
- +11.3%
Invested43KUSD
Dividends109.2KUSD
Capital gain489KUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.